Navigation Links
Orexigen® Therapeutics Reports Second Quarter Ended June 30, 2011 Financial Results
Date:8/8/2011

rm debt, current portion

2052,416Total current liabilities

9,23416,288Deferred revenue, less current portion

43,71446,311Other long-term liabilities

383459Commitments and contingenciesStockholders’ equity:Preferred stock, $.001 par value, 10,000,000 shares authorized at June 30, 2011 and December 31, 2010; noshares issued and outstanding at  June 30, 2011 and December 31, 2010--Common stock, $.001 par value, 300,000,000 and  100,000,000 shares authorized at June 30, 2011 and  December 31, 2010;48,084,692 and 47,767,313 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively

4848Additional paid-in capital

356,722352,401Accumulated other comprehensive income (loss)

6(9)Accumulated deficit

(337,823)(318,652)Total stockholders’ equity

18,95333,788Total liabilities and stockholders’ equity

$
72,284$
96,846
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity
2. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
3. Orexigen® Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet
4. Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
5. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
6. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
7. Orexigen® Therapeutics to Speak at Fifth Annual JMP Securities Healthcare Conference
8. Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
9. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
10. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
11. Orexigen® Therapeutics Schedules March 10, 2011 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... , Jan. 14, 2014 InformEx, North ... sellers of high-value chemistry, will hold the 30 th ... Beach Convention Center from January 21-24. ... attendees from top pharmaceutical, fine chemical and specialty chemical companies ...
(Date:1/14/2014)... Critical Care, a LifeCentre partner practice, located at 165 Fort Evans ... in Loudoun County to receive a small ... Barnes , Medical Director, is a well-seasoned veterinarian of more than ... are avid scuba divers. "As altitude skiers and hikers, we recognize ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2
... SUPERIOR, Colo., Jan. 10, 2011 Key Equipment ... finance companies and an affiliate of KeyCorp (NYSE: ... entered into an exclusive, long term, program agreement with ... America is the U.S. distributor of Hitachi Medical Corporation,s ...
... Jan. 8, 2011 - Bayer HealthCare Pharmaceuticals has become aware ... pads, swabs and swabsticks manufactured by the Triad Group and ... safety, Bayer wants to ensure that U.S. patients and physicians ... The recall of the Triad Group alcohol ...
Cached Medicine Technology:Key Equipment Finance Enters Long-Term Program Agreement With Hitachi Medical Systems America 2Key Equipment Finance Enters Long-Term Program Agreement With Hitachi Medical Systems America 3Important Information for Betaseron® (interferon beta 1-b) Consumers Regarding Triad Group's Alcohol Prep Products 2Important Information for Betaseron® (interferon beta 1-b) Consumers Regarding Triad Group's Alcohol Prep Products 3
(Date:7/9/2014)... BostonPractices used in policing injection drug users in ... mortality. , A study, conducted by researchers ... Health, in collaboration with St. Petersburg Pavlov State ... had on the health outcomes of a cohort ... use. , Those who were arrested by police ...
(Date:7/9/2014)... 2014 There has been a sharp increase in ... Center using MyChart, the online, interactive service that allows ... their healthcare providers, schedule appointments, and renew prescriptions. , ... using MyChart each year increased five-fold, while ... than 10-fold, according to a study by Dr. ...
(Date:7/9/2014)... have a reputation for being highly toxic, but when used ... being found to offer potential health benefits in a range ... A new compound (AP39), designed and made at the University ... targeting delivery of very small amounts of the substance to ... in Exeter have already found that the compound protects mitochondria ...
(Date:7/9/2014)... printing on prescription labels handed out by pharmacists ... in taking medication, according to new research by ... Institute for the Blind)., The study, published recently ... that labels on prescription medications dispensed by pharmacies ... legibility. , By simply following recommended guidelines for ...
(Date:7/9/2014)... The occurrence of allergic diseases has risen dramatically in ... are less exposed to microorganisms and have fewer infections ... system. , A study by researchers at Sahlgrenska Academy, ... three to examine maturation of the immune system in ... in rural areas of the Vstra Gtaland Region, half ...
Breaking Medicine News(10 mins):Health News:BU researchers relate arrests with HIV risk environment 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:Rotten egg gas holds key to healthcare therapies 2Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2
... help healthier people, but others worry about risks , ... Food and Drug Administration in February approved the use ... with normal cholesterol levels, cardiologist Dr. Steven ... go with the scientific evidence," said Nissen, who is ...
... ... facing executives and HR practitioners in a changing workplace at the 25th Meeting of ... ... deliver four noteworthy presentations at the 2010 Society for Industrial & Organizational Psychology Meeting ...
... ... Flow for Health Care Providers, Medical Facilities & Hospital’s, Reduces Patient Receivables, Reduces Patient-Pay ... Associated with Patient Billing and Collections , ... (PRWEB) April 2, 2010 -- Medical Pay Solutions, a national ...
... ... Legend is Officially Released and Now Available For Sale , ... New York, N.Y. (PRWEB) April 2, 2010 -- New ... Education of a Tennis Player,” is officially released today and is now available in book ...
... Value in Health , the study assessed the current ... fairness. The researchers concluded that extending the hotly-debated ... in terms of both economic efficiency and equity. The ... with similar age distributions. "Screening only older ...
... Memorial Health Care is undertaking an electronic medical record ... the project is a multi-year, multi-entity corporate initiative to ... reduce variability in processes and workflows across the system. ... over the next four years, the way UMass Memorial ...
Cached Medicine News:Health News:Should Cholesterol Drugs Be Used By Those Without High Cholesterol? 2Health News:Should Cholesterol Drugs Be Used By Those Without High Cholesterol? 3Health News:Atlanta Group Presents Issues in Business Psychology at National Conference 2Health News:Atlanta Group Presents Issues in Business Psychology at National Conference 3Health News:Atlanta Group Presents Issues in Business Psychology at National Conference 4Health News:Medical Pay Solutions Introduces the Revenue Maximizer to the Healthcare Industry; The Solution to 'Ever Increasing Direct To Patient Pay Issues' 2Health News:Medical Pay Solutions Introduces the Revenue Maximizer to the Healthcare Industry; The Solution to 'Ever Increasing Direct To Patient Pay Issues' 3Health News:Medical Pay Solutions Introduces the Revenue Maximizer to the Healthcare Industry; The Solution to 'Ever Increasing Direct To Patient Pay Issues' 4Health News:Medical Pay Solutions Introduces the Revenue Maximizer to the Healthcare Industry; The Solution to 'Ever Increasing Direct To Patient Pay Issues' 5Health News:Rod Laver Memoir 'The Education Of A Tennis Player' Officially Released By New Chapter Press 2Health News:Rod Laver Memoir 'The Education Of A Tennis Player' Officially Released By New Chapter Press 3Health News:UMass Memorial health care develops fully integrated EMR 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: